Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Philips

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cell|April 5, 2011
Directly observing therapy: a new view of drug tolerance in tuberculosisJennifer A Philips, Joel D Ernst
Annual Review of Pathology|November 8, 2011
Tuberculosis pathogenesis and immunityJennifer A Philips, Joel D Ernst
Nature Microbiology|May 26, 2026
Lysosomal cholesterol overload impairs the innate-adaptive immune axis in tuberculosis granulomasAndrew T Roth, Jennifer A Philips
Autophagy|January 10, 2018
Why macrophages cannot LAP up TBStefan Köster, Sandeep Upadhyay, Jennifer A Philips
Nature Reviews. Microbiology|July 25, 2022
Immune evasion and provocation by Mycobacterium tuberculosisPallavi Chandra, Steven J Grigsby, Jennifer A Philips
Science (New York, N.Y.)|July 16, 2005
Drosophila RNAi screen reveals CD36 family member required for mycobacterial infectionJennifer A Philips, Eric J Rubin, Norbert Perrimon
Immunometabolism (Cobham, Surrey)|May 2, 2024
The role of cholesterol and its oxidation products in tuberculosis pathogenesisAndrew T Roth, Jennifer A Philips, Pallavi Chandra
Vaccines|May 26, 2026
How <i>Mycobacterium tuberculosis</i> Subverts Innate and Adaptive Immunity and Their Crosstalk: Implications for Vaccine DesignG V R Krishna Prasad, Jennifer A Philips
The Journal of Clinical Investigation|February 1, 2022
Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infectionPallavi Chandra, Héloise Coullon, Mansi Agarwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
ESCRT factors restrict mycobacterial growthJennifer A Philips, Maura C Porto, Hui Wang, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cell|April 5, 2011
Directly observing therapy: a new view of drug tolerance in tuberculosisJennifer A Philips, Joel D Ernst
Annual Review of Pathology|November 8, 2011
Tuberculosis pathogenesis and immunityJennifer A Philips, Joel D Ernst
Nature Microbiology|May 26, 2026
Lysosomal cholesterol overload impairs the innate-adaptive immune axis in tuberculosis granulomasAndrew T Roth, Jennifer A Philips
Autophagy|January 10, 2018
Why macrophages cannot LAP up TBStefan Köster, Sandeep Upadhyay, Jennifer A Philips
Nature Reviews. Microbiology|July 25, 2022
Immune evasion and provocation by Mycobacterium tuberculosisPallavi Chandra, Steven J Grigsby, Jennifer A Philips
Science (New York, N.Y.)|July 16, 2005
Drosophila RNAi screen reveals CD36 family member required for mycobacterial infectionJennifer A Philips, Eric J Rubin, Norbert Perrimon
Immunometabolism (Cobham, Surrey)|May 2, 2024
The role of cholesterol and its oxidation products in tuberculosis pathogenesisAndrew T Roth, Jennifer A Philips, Pallavi Chandra
Vaccines|May 26, 2026
How <i>Mycobacterium tuberculosis</i> Subverts Innate and Adaptive Immunity and Their Crosstalk: Implications for Vaccine DesignG V R Krishna Prasad, Jennifer A Philips
The Journal of Clinical Investigation|February 1, 2022
Macrophage global metabolomics identifies cholestenone as host/pathogen cometabolite present in human Mycobacterium tuberculosis infectionPallavi Chandra, Héloise Coullon, Mansi Agarwal, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
ESCRT factors restrict mycobacterial growthJennifer A Philips, Maura C Porto, Hui Wang, et al.
Pageof 5